Latest Breaking News On - Jb lippincott company - Page 1 : comparemela.com

Age-related macular degeneration is an increasingly important public health issue due to ageing populations and increased longevity. Age-related macular degeneration affects individuals older than 55 years and threatens high-acuity central vision required for important tasks such as reading, driving, and recognising faces. Advances in retinal imaging have identified biomarkers of progression to late age-related macular degeneration. New treatments for neovascular age-related macular degeneration offer potentially longer-lasting effects, and progress is being made towards a treatment for atrophic late age-related macular degeneration.

United statesCity ofUnited kingdomSouth koreaEl mehdiMalattia leventineseQuezada ruizActa ophthalmolOliveira diasSemin ophthalmolClin ophthalmolNat genetDaich varelaUn department of economicLancet glob healthWomen health initiative